IDERA PHARMACEUTICAL IDRA (NASDAQ) $ 7.67 Change: -0.08 -1.04% | Volume: 88,135
Sponsored by Click here!

IDERA PHARMACT - Fundamental Profile

Company Information

Ticker Symbol: IDRA
Exchange: NASD
Contact Info: 167 Sidney Street Cambridge MA 02139 617 679-5500
CEO/President: Sudhir Agrawal
Industry: Medical - Biomedical / Standard Industry Code: 2836
Description: Idera Pharmaceuticals, Inc. is a drug discovery and development company that is developing drug candidates to treat cancer and infectious, respiratory, and autoimmune diseases, and for use in combination with therapeutic and prophylactic vaccines. Idera\'s proprietary drug candidates are designed to modulate Toll-like Receptors, the body\'s first line of immune defense. Idera\'s pioneering DNA chemistry expertise enables it to identify drug candidates for internal development and creates opportunities for multiple collaborative alliances.

Share Information

Shares Outstanding: 22,950 (000) Market Value: 183,820 ($000)
Percentage of Inst.Shareholders: 14.25% Number of Inst.Shareholders: 13.90%
Last Quarter Sales: 7.50 ($Mil.) Last Quarter Net Income: 1.98 ($Mil.)
Last Quarter EPS: 0.08 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -0.18
Most Recent Split: 1-8 on 06/30/06 Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +12.60 58.23
GILEAD SCIENCES -1.00 46.92
CELGENE CP -10.00 58.86
BIOGEN IDEC INC -31.90 43.52
AMYLIN PHARMA I -85.70 6.41